Novelix Pharmaceuticals Statistics
Total Valuation
BOM:536565 has a market cap or net worth of INR 1.10 billion. The enterprise value is 1.09 billion.
| Market Cap | 1.10B |
| Enterprise Value | 1.09B |
Important Dates
The last earnings date was Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:536565 has 17.62 million shares outstanding. The number of shares has increased by 63.39% in one year.
| Current Share Class | 17.62M |
| Shares Outstanding | 17.62M |
| Shares Change (YoY) | +63.39% |
| Shares Change (QoQ) | +20.19% |
| Owned by Insiders (%) | 41.75% |
| Owned by Institutions (%) | 1.42% |
| Float | 3.49M |
Valuation Ratios
The trailing PE ratio is 52.11.
| PE Ratio | 52.11 |
| Forward PE | n/a |
| PS Ratio | 0.86 |
| PB Ratio | 4.30 |
| P/TBV Ratio | 4.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 60.12 |
| EV / Sales | 0.85 |
| EV / EBITDA | 44.80 |
| EV / EBIT | 45.51 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.48% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.40% |
| Revenue Per Employee | 160.01M |
| Profits Per Employee | 2.26M |
| Employee Count | 8 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:536565 has paid 5.76 million in taxes.
| Income Tax | 5.76M |
| Effective Tax Rate | 24.20% |
Stock Price Statistics
The stock price has increased by +141.78% in the last 52 weeks. The beta is 0.39, so BOM:536565's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | +141.78% |
| 50-Day Moving Average | 59.09 |
| 200-Day Moving Average | 44.72 |
| Relative Strength Index (RSI) | 54.44 |
| Average Volume (20 Days) | 9,043 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:536565 had revenue of INR 1.28 billion and earned 18.06 million in profits. Earnings per share was 1.20.
| Revenue | 1.28B |
| Gross Profit | 38.93M |
| Operating Income | 23.85M |
| Pretax Income | 23.82M |
| Net Income | 18.06M |
| EBITDA | 24.23M |
| EBIT | 23.85M |
| Earnings Per Share (EPS) | 1.20 |
Balance Sheet
The company has 14.50 million in cash and n/a in debt, with a net cash position of 14.50 million or 0.82 per share.
| Cash & Cash Equivalents | 14.50M |
| Total Debt | n/a |
| Net Cash | 14.50M |
| Net Cash Per Share | 0.82 |
| Equity (Book Value) | 256.10M |
| Book Value Per Share | 17.77 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 3.04%, with operating and profit margins of 1.86% and 1.41%.
| Gross Margin | 3.04% |
| Operating Margin | 1.86% |
| Pretax Margin | 1.86% |
| Profit Margin | 1.41% |
| EBITDA Margin | 1.89% |
| EBIT Margin | 1.86% |
| FCF Margin | n/a |
Dividends & Yields
BOM:536565 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -63.39% |
| Shareholder Yield | -63.39% |
| Earnings Yield | 1.64% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 4, 2010. It was a reverse split with a ratio of 0.1.
| Last Split Date | Oct 4, 2010 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |